Zimmer Biomet Announces Fourth Quarter and Full-Year 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY23 Guidance
February 3, 2023 6:34 AM ESTZimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $1.88, $0.05 better than the analyst estimate of $1.83. Revenue for the quarter came in at $1.83 billion versus the consensus estimate of $1.76 billion.
GUIDANCE:
Zimmer Biomet Holdings sees FY2023 EPS of $6.95-$7.15, versus the... More



